1. Home
  2. FIEE vs PMN Comparison

FIEE vs PMN Comparison

Compare FIEE & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FiEE Inc

FIEE

FiEE Inc

HOLD

Current Price

$4.56

Market Cap

23.0M

Sector

Utilities

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$9.90

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FIEE
PMN
Founded
N/A
2004
Country
United States
Canada
Employees
43
N/A
Industry
Telecommunications Equipment
Pharmaceuticals and Biotechnology
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.0M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FIEE
PMN
Price
$4.56
$9.90
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
N/A
16.1K
Earning Date
N/A
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
$6.27
52 Week High
N/A
$39.75

Technical Indicators

Market Signals
Indicator
FIEE
PMN
Relative Strength Index (RSI) 74.42 75.46
Support Level $3.39 $8.08
Resistance Level $3.70 $8.51
Average True Range (ATR) 0.28 0.52
MACD 0.08 0.01
Stochastic Oscillator 81.53 84.70

Price Performance

Historical Comparison
FIEE
PMN

About FIEE FiEE Inc

FiEE Inc, formerly Minim Inc is a digital service provider focused on integrating artificial intelligence and data analytics into content creation and brand management. The company offers a range of services designed to support creators, artists, and businesses in developing, managing, and optimizing their digital presence across various platforms, including customized graphic and posts, short videos, and editorial calendars aligned with brand goals.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: